Medication
|
Benefit Category
|
Details
|
Link
|
| Abilify (aripiprazole) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=abilify&type=basic |
| Abilify Maintena (aripiprazole LAI) |
Exception drug status
|
For patients with schizophrenia: (a) With a history of non-adherence, as evidenced by outcomes such as repeated hospitalizations, or (b) Who have tried one or more antipsychotic agents, and who continue to be inadequately controlled, or are experiencing significant side effects such as EPS. |
https://www.gov.mb.ca/health/mdbif/docs/edsnotice.pdf |
| Clozaril (clozapine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=clozapine&type=basic |
| Invega (paliperidone) |
Not a Benefit |
|
|
| Invega Sustenna (paliperidone palmitate) |
Exception drug status |
For patients with schizophrenia: (a) With a history of non-adherence, as evidenced by outcomes such as repeated hospitalizations, or (b) Who have tried one or more antipsychotic agents, and who continue to be inadequately controlled, or are experiencing significant side effects such as EPS. |
https://www.gov.mb.ca/health/mdbif/docs/edsnotice.pdf |
| Invega Trinza (paliperidone palmitate) |
Exception drug status
|
For patients with schizophrenia: (a) With a history of non-adherence, as evidenced by outcomes such as repeated hospitalizations, or (b) Who have tried one or more antipsychotic agents, and who continue to be inadequately controlled, or are experiencing significant side effects such as EPS. NOTE: Invega Trinza to be used only after Invega Sustenna has been established as adequate treatment for at least four months. |
https://www.gov.mb.ca/health/mdbif/docs/edsnotice.pdf |
| Latuda (lurasidone) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=lurasidone&type=basic |
| Rexulti (brexpiprazole) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=rexulti&type=basic |
| Risperdal (risperidone) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=risperidone&type=basic&page=1 |
| Risperdal Consta (risperidone LAI) |
Exception drug status
|
For patients with schizophrenia: (a) With a history of non-adherence, as evidenced by outcomes such as repeated hospitalizations, or (b) Who have tried one or more antipsychotic agents, and who continue to be inadequately controlled, or are experiencing significant side effects such as EPS. |
https://www.gov.mb.ca/health/mdbif/docs/edsnotice.pdf |
| Saphris (asenapine) |
Not a benefit |
|
|
| Seroquel (quetiapine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=quetiapine&type=basic |
| Zeldox (ziprasidone) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=ziprasidone&type=basic |
| Zyprexa (olanzapine) |
Regular Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=olanzapine&type=basic&page=2 |
| Zyprexa IM (olanzapine injection) |
Not a benefit |
|
|
| Clopixol (zuclopenthixol) |
Not a Benefit |
|
|
| Fluanxol (flupentixol) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=fluanxol&type=basic |
| Modecate (Fluphenazine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=fluphenazine&type=basic |
| Haldol (haloperidol) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=haloperidol&type=basic |
| Largactil (chlorpromazine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=chlorpromazine&type=basic |
| Loxapac (loxapine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=loxapine&type=basic |
| Majeptil (thioproperazine) |
Not a benefit |
|
|
| Navane (thioxene) |
Not a benefit |
|
|
| Neuleptil (pericyazine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=neuleptil&type=basic |
| Nozinan (methotrimeprazine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=nozinan&type=basic |
| Orap (pimozide) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=pimozide&type=basic |
| Stelazine (trifluoperazine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=trifluoperazine&type=basic |
| Stemetil (prochlorperazine) |
General Benefit |
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=prochlorperazine&type=basic |
| Trilafon (perphenazine) |
General Benefit
|
|
https://web22.gov.mb.ca/eFormulary/searchResults.aspx?query=perphenazine&type=basic |